Olio Labs
Olio Labs designs combination therapies that aim to deliver better health outcomes with fewer side effects. Their platform utilizes AI to develop therapeutics that consider the complex interactions within the body, focusing on the development of combination treatments for challenging diseases.
Industries
artificial-intelligence
biopharma
biotechnology
machine-learning
therapeutics
Nr. of Employees
small (1-50)
Olio Labs
Products
Computational platform for designing combination therapies
A software-driven platform that integrates machine learning and systems biology models to propose multi-agent therapeutic combinations and analyze their predicted effects.
Computational platform for designing combination therapies
A software-driven platform that integrates machine learning and systems biology models to propose multi-agent therapeutic combinations and analyze their predicted effects.
Services
Clinical trial consulting
Advisory support for clinical trial protocol design and trial-related translational questions.
Computational collaboration for combination therapy design
Collaborative access to computational methods and engineering support for designing and evaluating multi-drug combinations.
Clinical trial consulting
Advisory support for clinical trial protocol design and trial-related translational questions.
Computational collaboration for combination therapy design
Collaborative access to computational methods and engineering support for designing and evaluating multi-drug combinations.
Expertise Areas
- Combination therapeutics design
- AI/ML for drug discovery
- Systems biology and network modeling
- Preclinical experimental research
Key Technologies
- Machine learning for therapeutics
- Computational modeling of protein interaction networks
- Drug combination prediction algorithms
- Preclinical laboratory assays